Search the Newsreel

$Mangoceuticals (MGRX.US)$

The article is a single comment from a user named "Darnelle Taught Me" on the moomoo community feed, referencing Mangoceuticals (MGRX.US). It appears to be a user-generated post within a financial social media platform, with a disclaimer about educational purposes.

MGRX surges after Nuclea Energy reverse-merger deal reshapes company story

Mangoceuticals, Inc. (MGRX) stock surged 172.5% today following its definitive business combination agreement with Nuclea Energy. This reverse-merger transforms MGRX from a telehealth company into a speculative nuclear-power listing, attracting significant investor interest. Nuclea Energy, a developer of advanced nuclear technology, is expected to …

$Mangoceuticals (MGRX.US)$ sold a tad early. but definitely looking for another entry!

A moomoo Community user, MsNoFomoTrade, commented on the stock $Mangoceuticals (MGRX.US), stating they sold their shares a bit prematurely but are actively seeking another entry point. The post indicates investor interest in re-engaging with the stock despite a previous early exit.

Mangoceuticals agrees to merge with nuclear microreactor developer By Investing.com

Mangoceuticals, Inc. (NASDAQ:MGRX) has announced a definitive merger agreement with Nuclea Energy Inc., a nuclear technology company developing the Morpheus microreactor. Under the terms, Nuclea will become an indirect wholly owned subsidiary of Mangoceuticals, with Nuclea shareholders receiving exchangeable shares in Mangoceuticals. The transaction, …

Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor

Nuclea Energy Inc. has entered into a definitive business combination agreement with Mangoceuticals, Inc. to gain a Nasdaq public listing, aiming to fund the development and commercialization of its Morpheus microreactor. This move positions Nuclea to capitalize on the increasing demand for continuous, carbon-free …

Mangoceuticals (MGRX) plans merger giving Nuclea Energy 96% post-close stake

Mangoceuticals, Inc. (MGRX) has entered a definitive business combination agreement with Nuclea Energy Inc., where a newly formed Mangoceuticals subsidiary will amalgamate with Nuclea. This merger is intended to provide Nuclea a pathway to a Nasdaq public listing and significant capital access for developing …

Mangalam Organics Reports Q1 FY27 Results: Consolidated Revenue Surges 22% YoY to ₹179.09 Crore

Mangoceuticals (MGRX) plans Nuclea merger, 96% new-owner stake, $15M PIPE

Mangoceuticals (MGRX) has announced a Business Combination Agreement with Nuclea Energy Inc. through which Nuclea shareholders will own approximately 96% of the combined entity on a fully diluted basis before PIPE financing, with existing Mangoceuticals stockholders retaining about 4%. The transaction involves a two-stage …

Mangoceuticals to Combine With Nuclea Energy; Nuclea Holders to Own ~96% Pre-PIPE

Mangoceuticals (MGRX) has entered into a Business Combination Agreement with Nuclea Energy, utilizing a Canadian exchangeable-share structure. Upon closing, Nuclea shareholders will receive exchangeable shares in a Mango subsidiary, which can be exchanged for Mango common stock. Former Nuclea holders are expected to own …

Mangoceuticals Deal Would Put Nuclea's ~3.5-50 MWe Reactor on Nasdaq Path

Mangoceuticals (NASDAQ: MGRX) has signed a definitive business combination agreement with Nuclea Energy, a Canadian developer of the lead-cooled Morpheus microreactor, to advance next-generation nuclear microreactor technology. The deal is structured to provide Nuclea a Nasdaq listing and offer Mangoceuticals shareholders exposure to the …

Jacob D. Cohen to Leave CEO Role at Mangoceuticals, Becomes President in Consulting Role

Jacob D. Cohen, CEO of Mangoceuticals (MGRX), will step down from his CEO role upon the closing of a transaction, transitioning instead to President in an independent consulting capacity. New executive officers will be appointed by the Principal Nuclea Shareholders, and existing executives not …

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Mangoceuticals, Inc. (NASDAQ: MGRX) has announced a definitive business combination agreement with Nuclea Energy Inc., a developer of advanced nuclear microreactor technology. This reverse merger will allow Nuclea to access public markets, aiming to capitalize on the increasing demand for continuous, carbon-free power driven …

Mangalam Cement cuts Scope 1 emissions 9.1% in FY26 BRSR filing

Mangalam Organics consolidated profit falls 41% in Q1FY27 despite revenue growth

Mangoceuticals Inc (MGRX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Mangoceuticals Inc (MGRX), noting its current valuation score of 9.10, which ranks 19th in the Healthcare Providers & Services industry. It states the company's P/E ratio is -0.42 but highlights that relevant data for P/B, P/S, and …

Mangalam Organics Q1FY27 profit falls 23% as material costs rise

Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Mangoceuticals Inc (MGRX), detailing its current risk score, beta value, and various volatility metrics. The company's risk score is 1.20, ranking 66 out of 75 in the Healthcare Providers & Services industry, with a beta of 0.00 …

Mangoceuticals Inc (MGRX) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Mangoceuticals Inc (MGRX), noting its current financial score of 5.70 and low operating efficiency. The company's latest quarterly revenue decreased by 37.91% year-over-year, and net profit declined by 29.68%. Key financial metrics for quality of earnings, …

Mangalam Global Enterprise Ltd. Revenue Breakdown – NSE:MGEL

Mangalam Global Enterprise Limited Approves the Final Dividend for the Financial Year Ended March 31, 2026

Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey reports on Mangoceuticals Inc (MGRX) revenue breakdown. However, it indicates that the company has not yet disclosed relevant data regarding its business segments, regional revenue, and profit contribution. The page displays current stock information and notes the absence of detailed …

Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Mangoceuticals Inc's (MGRX) shareholder structure, including major individual and institutional holdings. It lists the proportion of shares held by entities like Armistice Capital LLC, Cohen (Jacob D.), and Ikarian Capital LLC, as well as by different shareholder …

Mangalam Worldwide Q1 Results: Profit rises 19% to Rs 12 crore

Mangalam Worldwide posts ₹126 crore PAT in Q1FY27 on 13% revenue rise

Mangoceuticals Inc (MGRX) Income Statement

This article presents the quarterly and annual income statements for Mangoceuticals Inc (MGRX), providing detailed financial figures from FY2022Q3 to FY2026Q1, including revenue, cost of revenue, operating expenses, and net income. It also includes key financial metrics like EPS and offers an FAQ section …

Mangoceuticals Inc MGRX Cash Flow Statement

This article provides a detailed quarterly and annual cash flow statement for Mangoceuticals Inc (MGRX), including sections on operating, investing, and financing cash flows. It breaks down various components like net income, non-cash items, and changes in working capital, offering insight into the company's …

MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037

This article provides a financial overview of Mangoceuticals Inc. (MGRX), including its current stock price, market cap, and key financial summaries. It details the company's income statement, balance sheet, and cash flow statement, offering quarterly and annual data for various financial indicators. The report …

Mangalam Worldwide disputes BSE fine over alleged delay in financial results submission

Mangalam Worldwide Ltd. Revenue Breakdown – NSE:MWL

Mangoceuticals Inc (MGRX) Institutional Confidence

This article from TradingKey provides an overview of Mangoceuticals Inc (MGRX) with a focus on institutional confidence. It details key shareholder activities, including shares held and percentage changes by major institutional investors like Armistice Capital LLC, Cohen (Jacob D.), and Geode Capital Management. The …

Shringar House Of Mangalsutra Limited Revenue Breakdown – NSE:SHRINGARMS

MRPL shares zoom 11% after Q1 turnaround; revenue nearly doubles

MRPL soars 13% on strong Q1 result; analyst suggests buying on breakout

Mangalam Global Enterprise opens two new NEAT EVERYDAY stores

Mangalam Worldwide assigns new ISIN for stock split effective July 10

Mangalam Worldwide's (NSE:MWL) Earnings Are Weaker Than They Seem